P60 Evaluating Dynamic Treatment Using a Target Trial: The Real-World Effectiveness of Adding Oral Selexipag to a Double Oral Therapy for the Treatment of Patients With Pulmonary Arterial Hypertension
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.086
https://www.valueinhealthjournal.com/article/S1098-3015(24)00201-8/fulltext
Section Title :
Section Order :
10213
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00201-8&doi=10.1016/j.jval.2024.03.086